Radiopharm Theranostics Achieves Confirmed Durable PartialResponse in Ongoing Phase 1 Trial of RAD204 in Patients withAdvanced Solid Tumors Post-Immunotherapy
Radiopharm Theranostics Announces Positive Phase 2b Trial Resultsof RAD 101 for Diagnosis of Brain Metastases